EcoDrugPlus

Sodium/potassium-Transporting Atpase Subunit Beta-3-Like

Ensembl ID : ENSOKIG00005014845
Gene Symbol: LOC109874478
2 Cross references
230 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-3-Like

Ensembl ID : ENSOKIG00005036411
Gene Symbol: LOC109871845
3 Cross references
230 Possible Orthologues:

Solute Carrier Family 10 Member 2

Ensembl ID : ENSOKIG00005015494
Gene Symbol: SLC10A2
3 Cross references
214 Possible Orthologues:

Solute Carrier Family 18 Member A2

Ensembl ID : ENSOKIG00005046818
Gene Symbol: SLC18A2
1 Cross references
216 Possible Orthologues:

Solute Carrier Family 22 Member 15

Ensembl ID : ENSOKIG00005023299
Gene Symbol: SLC22A15
3 Cross references
196 Possible Orthologues:

Solute Carrier Family 29 Member 1 (Augustine Blood Group)

Ensembl ID : ENSOKIG00005006809
Gene Symbol: SLC29A1
1 Cross references
202 Possible Orthologues:

Solute Carrier Family 29 Member 1 (Augustine Blood Group)

Ensembl ID : ENSOKIG00005006610
Gene Symbol: SLC29A1
3 Cross references
202 Possible Orthologues:

Solute Carrier Family 29 Member 1 (Augustine Blood Group)

Ensembl ID : ENSOKIG00005037838
Gene Symbol: SLC29A1
1 Cross references
200 Possible Orthologues:

Solute Carrier Family 5 Member 1

Ensembl ID : ENSOKIG00005049218
Gene Symbol: SLC5A1
1 Cross references
244 Possible Orthologues:

Solute Carrier Family 5 Member 2

Ensembl ID : ENSOKIG00005025366
Gene Symbol: SLC5A2
1 Cross references
192 Possible Orthologues:

Solute Carrier Family 5 Member 2

Ensembl ID : ENSOKIG00005044952
Gene Symbol: SLC5A2
3 Cross references
193 Possible Orthologues:

Solute Carrier Family 6 Member 1

Ensembl ID : ENSOKIG00005017979
Gene Symbol: SLC6A1
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).